By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427



Company News
Amarantus BioSciences Forms Subsidiaries "Elto Pharma" To Focus On CNS Disorders And "MANF Therapeutics" To Focus On Ophthalmology 4/17/2017 9:40:36 AM
Amarantus BioSciences Enters Into A Letter Of Intent To Acquire Certain Biotechnology Assets From SeD BioMedical Inc. 2/28/2017 9:50:31 AM
Amarantus BioSciences Announces Passing of Biotechnology Legend Dr. Joseph Rubinfeld 2/10/2017 7:43:10 AM
Amarantus BioSciences Announces Publication Of Human Clinical Data For Engineered Skin Substitute In The Treatment Of Life-Threatening Pediatric Severe Burns 8/8/2016 11:21:30 AM
Amarantus BioSciences Announces Upcoming Investor Presentations 5/27/2016 10:23:31 AM
Amarantus BioSciences Announces Capital Infusion 4/25/2016 6:46:30 AM
Amarantus BioSciences Announces Cancellation Of Special Meeting Of Shareholders 3/22/2016 1:05:01 PM
Amarantus BioSciences Appoints Brian E. Harvey, MD PhD To Strategic Advisory Board 3/7/2016 6:56:58 AM
Amarantus BioSciences Receives Notices Of Allowance From European Patent Office For MANF And CDNF In The Treatment Of Retinal Disorders 2/29/2016 6:37:16 AM
Amarantus BioSciences To Present At Source Capital Group's 2016 Disruptive Growth & Healthcare Conference 2/10/2016 10:08:03 AM